These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 33006772

  • 1. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC, Fung JY, Pang HH, Leung CK, Li HF, Sin SL, Ma KW, She BW, Dai JW, Chan AC, Cheung TT, Lo CM.
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [Abstract] [Full Text] [Related]

  • 2. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL, Ng KKC, Fung JYY, Chan AAC, Cheung TT, Chok KSH, Dai JWC, Lo CM.
    Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
    [Abstract] [Full Text] [Related]

  • 3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 4. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH, Kim DG, Kang M, Koh HH, Choi MC, Min EK, Lee JG, Kim MS, Joo DJ.
    Int J Surg; 2023 Nov 01; 109(11):3459-3466. PubMed ID: 37565633
    [Abstract] [Full Text] [Related]

  • 5. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan 01; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 6. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson GE, Foley D, Mezrich JD, Kanmaz T, Andaçoğlu OM, D'Alessandro AM, Acarlı KS, Kalayoğlu M, Fernandez LA.
    Turk J Med Sci; 2021 Apr 30; 51(2):610-622. PubMed ID: 33037873
    [Abstract] [Full Text] [Related]

  • 7. Sex Disparity in Liver Transplant and Access to Living Donation.
    Karnam RS, Chen S, Xu W, Chen C, Elangainesan P, Ghanekar A, McGilvray I, Reichman T, Sayed B, Selzner M, Sapisochin G, Galvin Z, Hirschfield G, Asrani SK, Selzner N, Cattral M, Lilly L, Bhat M.
    JAMA Surg; 2021 Nov 01; 156(11):1010-1017. PubMed ID: 34406347
    [Abstract] [Full Text] [Related]

  • 8. Living vs. deceased donor liver transplantation provides comparable recovery of renal function in patients with hepatorenal syndrome: a matched case-control study.
    Goldaracena N, Marquez M, Selzner N, Spetzler VN, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M.
    Am J Transplant; 2014 Dec 01; 14(12):2788-95. PubMed ID: 25277134
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation.
    Lee JP, Kwon HY, Park JI, Yi NJ, Suh KS, Lee HW, Kim M, Oh YK, Lim CS, Kim YS.
    Liver Transpl; 2012 Oct 01; 18(10):1237-44. PubMed ID: 22714872
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 11. Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysis.
    Jones O, Claasen MPAW, Ivanics T, Choi WJ, Gavaria F, Rajendran L, Ghanekar A, Hirschfield G, Gulamhusein A, Shwaartz C, Reichman T, Sayed BA, Selzner M, Bhat M, Tsien C, Jaeckel E, Lilly L, McGilvray ID, Cattral MS, Selzner N, Sapisochin G.
    Liver Transpl; 2024 Aug 01; 30(8):785-795. PubMed ID: 38619393
    [Abstract] [Full Text] [Related]

  • 12. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C, Liu H, Zhang X, Ganoza A, Crane A, Powers C, Gunabushanam V, Behari J, Molinari M.
    BJS Open; 2024 May 08; 8(3):. PubMed ID: 38837956
    [Abstract] [Full Text] [Related]

  • 13. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.
    Transplant Proc; 2015 May 08; 47(4):1211-3. PubMed ID: 26036556
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
    Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL, A2ALL Study Group.
    Am J Transplant; 2007 Jun 08; 7(6):1601-8. PubMed ID: 17511683
    [Abstract] [Full Text] [Related]

  • 15. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
    Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, Castaing D, Cherqui D, Irtan S, Calmus Y, Chazouillères O, Soubrane O, Luciani A, Feray C.
    Ann Surg; 2017 Dec 08; 266(6):1035-1044. PubMed ID: 27617853
    [Abstract] [Full Text] [Related]

  • 16. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov 08; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 17. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW, Katchman H, Tanaka T, Greig PD, McGilvray ID, Cattral MS, Renner EL, Selzner M, Ghanekar A, Levy G, Grant DR.
    Transpl Int; 2013 Aug 08; 26(8):780-7. PubMed ID: 23746118
    [Abstract] [Full Text] [Related]

  • 18. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S.
    Liver Transpl; 2021 Jul 08; 27(7):971-983. PubMed ID: 33492764
    [Abstract] [Full Text] [Related]

  • 19. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS, Ruebner RL, Abt PL.
    Am J Transplant; 2015 Oct 08; 15(10):2732-8. PubMed ID: 25969133
    [Abstract] [Full Text] [Related]

  • 20. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A, Ganesh S, Jorgensen D, Tevar A, Ganoza A, Molinari M, Hughes C.
    Ann Surg; 2019 Sep 08; 270(3):444-451. PubMed ID: 31305283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.